“Sample tracking and reconciliation are so much easier when all information around sample status, consent, and location are in one place.”
–Director of Biomarker Operations, QuartzBio Client Company N
Watch our webinar to learn how our clients, representing major biopharmas and biotechnology companies, have eliminated tedious data management processes and costly delays with the QuartzBio® virtual Sample Inventory Management SaaS solution.
QuartzBio’s Adam Brown, PhD, demonstrates new capabilities of our technology, enabling teams to:
Track samples across every stage of their lifecycle with dynamic reports comparing actual and expected sample status
Proactively monitor sample stability and consent expiration with automated notifications
Quickly and accurately identify samples to ship for testing using intuitive Sample Ship List generator
Report on portfolio-level metrics and vendor and site performance across all clinical programs, including closed and active studies, to inform future planning
Adam also shows QuartzBio’s reimagined user interface*, which empowers teams to gain insights efficiently without requiring data expertise. Whether you are a current user or learning about the technology for the first time, you will learn new ways to immediately begin streamlining your work.
*Current QuartzBio Users: Questions about when you can expect rollout of the new user interface for your account? Contact us!
https://www.quartz.bio/wp-content/uploads/2024/08/QuartzBio-Digitizing-Biomarker-Operations-webinar-June-2023.png12021200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2023-05-31 16:46:002024-08-23 16:23:58Webinar On Demand: Digitizing Biomarker Operations–Tools to Track & Report Sample, Consent, Vendor, & Site KPIs Across Programs
Duration: 30 minutes
Register to watch on demand:
Complex sample operations, disparate vendors, inconsistent metadata across labs are common challenges sponsors face when keeping track of samples across clinical programs.
Join our webinar to learn how sponsor teams are creating consistent, portfolio-level approaches for tracking sample status and location and uncovering insights into vendor/site/country-level performance.
https://www.quartz.bio/wp-content/uploads/2024/08/20230201-vSIM-Webinar-QuartzBio-Clinical-Sample-Chaos-On-Demand.png12011200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2023-01-10 17:09:332024-08-23 16:24:02Webinar: Clinical Sample Chaos – Tracking and Reporting Metrics Across Clinical Programs
December 10, 2020 — Biomarker-guided trials frequently have an international footprint of sites to reach targeted patient populations and involve a complex network of specialty labs. Join us for our upcoming webinar, where QuartzBio’s Tobi Guennel will discuss how his team is breaking down data siloes to create actionable insights into availability and quality of samples and data. These insights allow clinical and translational teams to streamline trial operations and enable early course correction.
https://www.quartz.bio/wp-content/uploads/2024/08/Picture19.jpg342653QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2022-12-10 22:00:002025-01-23 15:50:55Centralizing PK, Clinical, and Exploratory Data to Streamline Biomarker-Centric Trial Operations
Translational and clinical teams spend more than 70% of their time managing, cleaning, and harmonizing data generated in biomarker-rich clinical programs.
In a webinar now available on demand, we demonstrated how the QuartzBio® enterprise Biomarker Data Management (eBDM) solution addresses one set of frequently intractable challenges: connecting raw, processed, and ancillary data across multiple clinical studies.
Multiple Assay Modalities, File Types, Data Storage Locations
As we have previously described, research teams are generating biomarker data from a wide variety of assay modalities, and this data can be housed in multiple, disconnected storage locations. In the example use case described in the webinar, data was being generated from targeted assays like flow cytometry and immunohistochemistry to high-throughput omics assays.
The QuartzBio eBDM solution is specifically engineered to ingest, standardize, visualize, and analyze this data. The unified data platform connects raw and processed data to ancillary files, such as the images used for immunohistochemistry quantification or PDF omics reports. All of the raw files are available for download individually or in bulk. They can also be previewed directly within the user interface.
As shown in Video 1, the QuartzBio enterprise data platform can centralize and harmonize data from multiple file types across clinical programs, including:
Image files
Tabular files
Omics files, e.g., BAM or VCF files
Sequencing reports for particular mutations or genomic regions of interest
Video 1 (Click image to view video): The QuartzBio enterprise data platform can centralize and harmonize data from multiple file types across clinical programs. Video demonstrates access to images, PDF files, and genomics data.
As shown in Video 2, the QuartzBio eBDM solution can combine processed files with harmonized clinical annotations, with both subject and sample level data, as well as the relevant quantified reportables for a specific assay modality. These reportables are very configurable and can be changed according to the needs of a sponsor, a program, or even a specific study.
Video 2 (Click image to view video): Processed files combine harmonized clinical annotations with both subject- and sample-level data.
The QuartzBio team can also further preprocess raw assay data directly and apply quality control metrics as well as normalization techniques. We can also extract relevant data and metadata from PDFs, such as omics reports and informed consent forms.
In summary, the webinar demonstrated how the biomarker data modules of the QuartzBio platform can enable easy access to both key raw and processed data assets through the user interface, in addition to robust visualization and data exploration capabilities.
Flexible Biomarker Data Management Means Faster Deployment
QuartzBio’s enterprise-grade Biomarker Data Management application provides a flexible, scalable solution for transforming biomarker data into consumable information across a sponsor’s entire study portfolio.
This resilient approach is enabled by a robust enterprise data platform with a library of pre-built, configuration-ready pipelines for data ingestion.
Contact us to learn more about data management SaaS solutions and let us know which additional features and capabilities you’d like featured in our next webinar.
https://www.quartz.bio/wp-content/uploads/2022/10/Linkedin_Connecting-Data_Blog_1200x1200.jpg12001200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2022-10-31 14:32:362024-12-06 11:53:53Connecting Raw, Processed, and Ancillary Data with a Biomarker Data Management Solution
Translational and clinical research teams spend more than 70% of their time wrangling information from disconnected clinical trial data sets.
Data ends up in silos, making it hard to compile information and surface insights.
Watch this short webinar, where Adam Brown and Mike Waters will demonstrate how integrating exploratory biomarker, PK, and clinical data in a unified data platform enables teams to interrogate trends and identify insights as data is generated on-study.
Translational and clinical research teams spend more than 70% of their time wrangling information from disconnected clinical trial data sets.
Data ends up in silos, making it hard to compile information and surface insights.
Watch this short webinar, where Adam Brown and Mike Waters will demonstrate how integrating exploratory biomarker, PK, and clinical data in a unified data platform enables teams to interrogate trends and identify insights as data is generated on-study.
https://www.quartz.bio/wp-content/uploads/2024/08/BDM-14SEP-Landing-page-archive-image.jpg12001200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2022-08-17 22:04:032024-08-23 16:24:04Webinar: Overcoming Biomarker Data Chaos with a Single Data Platform
Clinical and translational teams must monitor biomarker samples across global site footprints and dispersed networks of labs and biorepositories.
It’s easy to get bogged down by managing the day-to-day requirements of keeping studies on track. With samples as the critical first step toward data generation, modern trials demand a unified approach for evaluating vendor and site performance and their impact on sample operations.
Join our webinar to learn how our team has been working with sponsor clients to create program- and enterprise-wide visibility into site and vendor metrics that inform future study planning.
We will show how clients are using key performance indicators (KPIs) including:
Protocol & consent deviations – compare planned vs actual events at sites and labs, including unexpected or unconsented sample collections
Turnaround times – monitor sample receipt to testing and data delivery
Sample handling & movements – uncover trends at sites and vendors, such as samples that have been delivered past processing windows
Sample metadata – including processing volume and quality metrics such as cell count and viability
You’ll see how teams are gaining visibility into these KPIs to streamline daily operations, while simultaneously revealing program-wide insights.
QuartzBio, part of Precision for Medicine, delivers software-as-a-service (SaaS) solutions to accelerate drug development.
https://www.quartz.bio/wp-content/uploads/2022/06/Linkedin_Monitor-Vendor_Webinar_1200x1200.jpg12001200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2022-06-03 00:49:352024-10-29 15:03:50Webinar: Monitoring Site and Vendor Performance Metrics Across Studies
Title: Critical Biomarker Operations KPIs Across Clinical Portfolios
Duration: 30 minutes
Clinical and biomarker operations teams face challenges with global site footprints, complex sample lifecycles, and inconsistent naming across sites and vendors.
Watch our webinar to learn how teams are monitoring key performance indicators (KPIs) for clinical sample status, quality, and data availability – on-study and across clinical portfolios.
Adam S. Brown, PhD of QuartzBio will share how teams are assessing key deliverables:
Site performance including collection rates, collection quality metrics, and automated reporting for consent and protocol violations.
Vendor operational performance such as adherence to contracted turnaround windows and time to analysis.
Results data availability across assay modalities at study, cohort, patient, and sample levels – with comparisons of actual vs expected events, and forward-looking projections.
Sample and derivative availability across active and completed studies, including in-depth profiling of viability and volume, consent status, and expiration dates.
https://www.quartz.bio/wp-content/uploads/2024/08/Bioinformatics-Strategy-Meeting-QuartzBio-2022.png7161367QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2022-03-15 22:14:592022-03-15 22:14:59May 23: Join QuartzBio at the Bioinformatics Strategy Meeting East Coast
February 18, 2022 — At our first in-person conference in over a year, the QuartzBio team had a chance to connect with biomarker operations and clinical operations teams in Orlando, Florida, earlier this month.
In the “Clinical Biomarkers Operations and Innovation” track, we joined discussions on the latest approaches to structuring clinical sample management to best support complex biomarker-informed clinical trials.
Here are three recurring challenges we heard about at SCOPE this year:
